Placentation is a key and tightly regulated process that ensures the normal development of
the placenta and fetal growth. Preeclampsia (PE) is a hypertensive pregnancy-related …

CD93 (also known as complement protein 1 q subcomponent receptor C1qR1 or C1qRp), is
a transmembrane glycoprotein encoded by a gene located on 20p11. 21 and composed of …

Non-alcoholic fatty liver disease (NAFLD) is by far the most prevalent form of liver disease
worldwide. It's also the leading cause of liver-related hospitalizations and deaths …

Gestational diabetes mellitus (GDM) is a severe pregnancy complication for both the woman
and the child. Women who suffer from GDM have a greater risk of developing Type 2 …

The rising prevalence of liver diseases related to obesity and excessive use of alcohol is
fuelling an increasing demand for accurate biomarkers aimed at community screening …

Objective We investigated the potential involvement of miRNAs in the developmental
programming of cardiovascular diseases (CVD) by maternal obesity. Methods Serum …

Non‐alcoholic fatty liver disease (NAFLD) represents a growing global health concern that
can lead to liver disease and cancer. It is characterized by an excessive accumulation of fat …

In recent years, EVs have emerged as promising vehicles for coding and non-coding RNAs
(ncRNAs), which have demonstrated remarkable potential as biomarkers for various …

Non-alcoholic fatty liver disease (NAFLD) is a liver disorder that has become a global health
concern due to its increasing prevalence. There is a need for reliable biomarkers to aid in …

Obesity is an important risk factor for cardiovascular disease and type 2 diabetes mellitus.
Even a modest weight loss of 5–15% improves metabolic health, but circulating markers to …